ImmuCell Debt to Equity Ratio 2010-2025 | ICCC
Current and historical debt to equity ratio values for ImmuCell (ICCC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ImmuCell debt/equity for the three months ending March 31, 2025 was 0.30.
| ImmuCell Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.02B | $0.03B | 0.57 |
| 2024-12-31 | $0.02B | $0.03B | 0.64 |
| 2024-09-30 | $0.02B | $0.03B | 0.68 |
| 2024-06-30 | $0.02B | $0.02B | 0.78 |
| 2024-03-31 | $0.02B | $0.03B | 0.75 |
| 2023-12-31 | $0.02B | $0.03B | 0.75 |
| 2023-09-30 | $0.02B | $0.03B | 0.71 |
| 2023-06-30 | $0.02B | $0.03B | 0.64 |
| 2023-03-31 | $0.02B | $0.03B | 0.53 |
| 2022-12-31 | $0.01B | $0.03B | 0.48 |
| 2022-09-30 | $0.01B | $0.03B | 0.45 |
| 2022-06-30 | $0.01B | $0.03B | 0.41 |
| 2022-03-31 | $0.01B | $0.03B | 0.41 |
| 2021-12-31 | $0.01B | $0.03B | 0.37 |
| 2021-09-30 | $0.01B | $0.03B | 0.36 |
| 2021-06-30 | $0.01B | $0.03B | 0.36 |
| 2021-03-31 | $0.01B | $0.03B | 0.42 |
| 2020-12-31 | $0.01B | $0.03B | 0.43 |
| 2020-09-30 | $0.01B | $0.03B | 0.43 |
| 2020-06-30 | $0.01B | $0.03B | 0.44 |
| 2020-03-31 | $0.01B | $0.03B | 0.38 |
| 2019-12-31 | $0.01B | $0.03B | 0.34 |
| 2019-09-30 | $0.01B | $0.03B | 0.33 |
| 2019-06-30 | $0.01B | $0.03B | 0.33 |
| 2019-03-31 | $0.01B | $0.03B | 0.34 |
| 2018-12-31 | $0.01B | $0.02B | 0.51 |
| 2018-09-30 | $0.01B | $0.02B | 0.47 |
| 2018-06-30 | $0.01B | $0.02B | 0.44 |
| 2018-03-31 | $0.01B | $0.02B | 0.43 |
| 2017-12-31 | $0.01B | $0.02B | 0.45 |
| 2017-09-30 | $0.01B | $0.02B | 0.45 |
| 2017-06-30 | $0.01B | $0.02B | 0.39 |
| 2017-03-31 | $0.01B | $0.02B | 0.24 |
| 2016-12-31 | $0.01B | $0.02B | 0.25 |
| 2016-09-30 | $0.00B | $0.02B | 0.25 |
| 2016-06-30 | $0.00B | $0.02B | 0.26 |
| 2016-03-31 | $0.00B | $0.02B | 0.25 |
| 2015-12-31 | $0.00B | $0.01B | 0.37 |
| 2015-09-30 | $0.00B | $0.01B | 0.38 |
| 2015-06-30 | $0.00B | $0.01B | 0.14 |
| 2015-03-31 | $0.00B | $0.01B | 0.15 |
| 2014-12-31 | $0.00B | $0.01B | 0.19 |
| 2014-09-30 | $0.00B | $0.01B | 0.18 |
| 2014-06-30 | $0.00B | $0.01B | 0.18 |
| 2014-03-31 | $0.00B | $0.01B | 0.18 |
| 2013-12-31 | $0.00B | $0.01B | 0.17 |
| 2013-09-30 | $0.00B | $0.01B | 0.16 |
| 2013-06-30 | $0.00B | $0.01B | 0.20 |
| 2013-03-31 | $0.00B | $0.01B | 0.18 |
| 2012-12-31 | $0.00B | $0.01B | 0.20 |
| 2012-09-30 | $0.00B | $0.01B | 0.19 |
| 2012-06-30 | $0.00B | $0.01B | 0.19 |
| 2012-03-31 | $0.00B | $0.01B | 0.21 |
| 2011-12-31 | $0.00B | $0.01B | 0.22 |
| 2011-09-30 | $0.00B | $0.01B | 0.22 |
| 2011-06-30 | $0.00B | $0.01B | 0.25 |
| 2011-03-31 | $0.00B | $0.01B | 0.23 |
| 2010-12-31 | $0.00B | $0.01B | 0.16 |
| 2010-09-30 | $0.00B | $0.01B | 0.15 |
| 2010-06-30 | $0.00B | $0.01B | 0.03 |
| 2010-03-31 | $0.00B | $0.01B | 0.04 |
| 2009-12-31 | $0.00B | $0.01B | 0.04 |
| 2009-09-30 | $0.00B | $0.01B | 0.03 |
| 2009-06-30 | $0.00B | $0.01B | 0.04 |
| 2009-03-31 | $0.00B | $0.01B | 0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.057B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |